Putrescine produces antidepressant-like effects in the forced swimming test and in the tail suspension test in mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 8, 2006, Pages 1419-1425

  Zomkowski, Andrea D E ^a   Santos, Adair Roberto S ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Depression; Forced swimming test; Polyamines; Putrescine; Tail suspension test

Indexed keywords

AGMATINE; ARCAINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PUTRESCINE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FORCED SWIMMING TEST; LOCOMOTION; MOUSE; NONHUMAN; OPEN FIELD TEST;

AGMATINE; ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISEASE MODELS, ANIMAL; FEMALE; IMIPRAMINE; IMMOBILIZATION; MALE; MICE; PUTRESCINE; RESTRAINT, PHYSICAL; SWIMMING; TAIL;

EID: 33750352828     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.05.016     Document Type: Article

References (49)

1. Adibhatla R.M., Hatcher J.F., Sailor K., and Dempsey R.J. Polyamines and central nervous system injury: spermine and spermidine decrease following transient focal cerebral ischemia in spontaneously hypertensive rats. Brain Res 938 (2002) 81-86
2. Almeida R.C., Souza D.G., Soletti R.C., Lopez M.G., Rodrigues A.L.S., and Gabilan N.H. Involvement of PKA, MAPK/ERK and CaMKII, but not PKC in the acute antidepressant-like effect of memantine in mice. Neurosci Lett 395 (2006) 93-97
3. Bellé N.A., Dalmolin G.D., Fonini G., Rubin M.A., and Rocha J.B. Polyamines reduces lipid peroxidation induced by different pro-oxidant agents. Brain Res 1008 (2004) 245-251
4. Bourin M., Fiocco A.J., and Clenet F. How valuable are animal models in defining antidepressant activity?. Hum Psychopharmacol 16 (2001) 9-21
5. Clarkson A.N., Liu H., Pearson L., Kapoor M., Harrison J.C., Sammut I.A., et al. Neuroprotective effects of spermine following hypoxic-ischemic-induced brain damage: a mechanistic study. FASEB J 18 (2004) 1114-1116
6. Cryan J.F., Markou A., and Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23 (2002) 238-245
7. Doyle K.M., and Shaw G.G. Investigation of the actions and antagonist activity of some polyamine analogues in vivo. Br J Pharmacol 124 (1998) 386-390
8. Dudkowska M., Lai J., Gardini G., Stachurska A., Grzelakowska-Sztabert B., Colombatto S., et al. Agmatine modulates the in vivo biosynthesis and interconversion of polyamines and cell proliferation. Biochim Biophys Acta 1619 (2003) 159-166
9. Eckeli A.L., Dach F., and Rodrigues A.L.S. Acute treatments with GMP produce antidepressant-like effects in mice. NeuroReport 11 (2000) 1839-1843
10. Fraser C.M., Cooke M.J., Fisher A., Thompson I.D., and Stone T.W. Interactions between ifenprodil and dizocilpine on mouse behaviour in models of anxiety and working memory. Eur Neuropsychopharmacol 6 (1996) 311-316
11. Genedani S., Piccinini G., and Bertolini A. Putrescine has analgesic activity, in rats. Life Sci 34 (1984) 2407-2412
12. Genedani S., Saltini S., Benelli A., Filaferro M., and Bertolini A. Influence of SAM on the modifications of brain polyamine levels in an animal model of depression. NeuroReport 12 (2001) 3939-3942
13. Gibson D.A., Harris B.R., Rogers D.T., and Littleton J.M. Radioligand binding studies reveal agmatine is a more selective antagonist for a polyamine on the NMDA than arcaine or ifenprodil. Brain Res 952 (2002) 71-77
14. Hillary R.A., and Pegg A.E. Decarboxylases involved in polyamines biosynthesis and their inactivation by nitric oxide. Biochim Biophys Acta 1647 (2003) 161-166
15. Johnson T.D. Modulation of channel function by polyamines. Trends Pharmacol Sci 17 (1996) 22-27
16. Kolhekar R., Meller S.T., and Gebhart G.F. N-methyl-d-aspartate receptor-mediated changes in thermal nociception: allosteric modulation at glycine and polyamine recognition sites. Neuroscience 63 (1994) 925-936
17. Layer R.T., Popik P., Olds T., and Skolnick P. Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Pharmacol Biochem Behav 52 (1995) 621-627
18. Li Y.F., Gong Z.H., Cao J.B., Wang H.L., Luo Z.P., and Li J. Antidepressant-like effect of agmatine and its possible mechanism. Eur J Pharmacol 469 (2003) 81-88
19. Matthews K., Christmas D., Swan J., and Sorrell E. Animal models of depression: navigating through the clinical fog. Neurosci Biobehav Rev 29 (2005) 503-513
20. Mikolajczak P., Okulicz-Kozaryn I., Kaminska E., Nielopad L., Polanska A., and Gebka J. Effects of acamprosate and some polyamine site ligands of NMDA receptor on short-term memory in rats. Eur J Pharmacol 444 (2002) 83-96
21. Moinard C., Cynober L., and de Bandt J.P. Polyamines: metabolism and implications in human diseases. Clin Nutr 24 (2005) 184-197
22. Moryl E., Danysz W., and Quack G. Potential antidepressive properties of amantadine, memantine and bifemelane. Pharmacol Toxicol 72 (1993) 394-397
23. 3H]MK-801 binding to NMDA receptors in vivo and in vitro. Eur J Pharmacol 397 (2000) 263-270
24. Palucha A., and Pilc A. The involvement of glutamate in the pathophysiology of depression. Drug News Perspect 18 (2005) 262-268
25. Piletz J.E., May P.J., Wang G., and Zhu H. Agmatine crosses the blood-brain barrier. Ann N Y Acad Sci 1009 (2003) 64-74
26. Pláteník J., Kuramato N., and Yoneda Y. Molecular mechanisms associated with long-term consolidation of the NMDA signals. Life Sci 67 (2000) 335-364
27. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229 (1977) 327-336
28. Raasch W., Schafer U., Qadri F., and Dominiak P. Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction. Br J Pharmacol 135 (2002) 663-672
29. Reis D.J., and Regunathan S. Is agmatine a novel neurotransmitter in brain?. Trends Pharmacol Sci 21 (2000) 187-193
30. Reynolds I.J. Arcaine uncovers dual interactions of polyamines with the N-methyl-d-aspartate receptor. J Pharmacol Exp Ther 255 (1990) 1001-1007
31. Riedel G., Platt B., and Micheau J. Glutamate receptor function in learning and memory. Behav Brain Res 140 (2003) 1-47
32. Roberts J.C., Grocholski B.M., Kitto K.F., and Fairbanks C.A. Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse. J Pharmacol Exp Ther 314 (2005) 1226-1233
33. Rock D.M., and MacDonald R.L. Spermine and related polyamines produce a voltage-dependent reduction of N-methyl-d-aspartate receptor single-channel conductance. Mol Pharmacol 42 (1992) 157-164
34. Rock D.M., and Macdonald R.L. Polyamine regulation of N-methyl-d-aspartate receptor channels. Annu Rev Pharmacol Toxicol 35 (1995) 463-482
35. Rubin M.A., Boemo R.L., Jurach A., Rojas D.B., Zanolla G.R., Obregon A.D.C., et al. Intrahippocampal spermidine administration improves inhibitory avoidance performance in rats. Behav Pharmacol 11 (2000) 57-62
36. Rubin M.A., Stiegemeier J.A., Volkweis M.A., Oliveira D.M., Fenili A.C., Boemo R.L., et al. Intra-amygdala spermidine administration improves inhibitory avoidance performance in rats. Eur J Pharmacol 423 (2001) 35-39
37. Rubin M.A., Berlese D.B., Stiegemeier J.A., Volkweis M.A., Oliveira D.M., dos Santos T.L., et al. Intra-amygdala administration of polyamines modulates fear conditioning in rats. J Neurosci 24 (2004) 2328-2334
38. Satriano J., Isome M., Casero R.A., Thomson S.C., and Blantz R.C. Polyamine transport system mediates agmatine transport in mammalian cells. Am J Physiol Cell Physiol 281 (2001) C329-C334
39. Schechter L.E., Ring R.H., Beyer C.E., Hughes Z.A., Khawaja X., Malberg J.E., et al. Innovative approaches for the development of antidepressant drugs: current and future strategies. NeuroRx 2 (2005) 590-611
40. Skolnick P. Antidepressants for the new millennium. Eur J Pharmacol 375 (1999) 31-40
41. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85 (1985) 367-370
42. Williams K. Interaction of polyamines with ion channels. Biochem J 325 (1997) 289-297
43. Williams K. Modulation and block of ion channels: a new biology of polyamines. Cell Signal 9 (1997) 1-13
44. 3H]MK-801 to the N-methyl-d-aspartate receptor: pharmacological evidence for the existence of a polyamine recognition site. Mol Pharmacol 36 (1989) 575-581
45. Willner P. The validity of animal models of depression. Psychopharmacology 83 (1984) 1-16
46. Zarate Jr. C.A., Singh J.B., Quiroz J.A., De Jesus G., Denicoff K.K., Luckenbaugh D.A., et al. A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am J Psychiatry 163 (2006) 153-155
47. Zomkowski A.D.E., Hammes L., Lin J., Calixto J.B., Santos A.R.S., and Rodrigues A.L.S. Agmatine produces antidepressant-like effects in two models of depression in mice. NeuroReport 13 (2002) 387-391
48. Zomkowski A.D.E., Rosa A.O., Lin J., Santos A.R.S., Calixto J.B., and Rodrigues A.L.S. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant-like effect in the mouse forced swimming test. Brain Res 1023 (2004) 253-263
49. Zomkowski A.D.E., Santos A.R.S., and Rodrigues A.L.S. Involvement of opioid system in the agmatine antidepressant-like effect in the forced swimming test. Neurosci Lett 381 (2005) 279-283